1,2 dipalmitoyl sn glycero 3 phosphoethanolamine

DPPE-PEG2000 (16:0 PEG2000 PE) is a PEG-modified lipid known for reducing nonspecific protein adsorption and extending circulation time in vivo.

DPPE-PEG550 serves as a PEG lipid functional terminal group used for synthesizing liposomes (LPs) to design conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) are capable of further coupling with other biomolecules through biotin modification and carboxyl terminals. Functionalized nanoparticles can target specific cell proteins for labeling purposes. Using streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind with biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.

DPPE-PEG750 is a PEG lipid functional end group used for synthesizing liposomes (LPs) and designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) modified with biotin and carboxylic ends can couple with other biomolecules. These functionalized nanoparticles are useful for targeting specific cell proteins. Using streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, facilitating fluorescence-based imaging and sensing applications.

DPPE-PEG1000 is a PEG lipid functional end group used for synthesizing liposomes (LPs) and is instrumental in designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs), featuring biotin modification and carboxyl terminals, can further couple with other biomolecules. These functionalized nanoparticles are useful for the targeted labeling of specific cell proteins. By employing streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.

DPPE-PEG3000 is a PEG lipid functional end group used for synthesizing liposomes (LPs) and designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) modified with biotin and having a carboxylate end can further couple with other biomolecules. The functionalized nanoparticles are applicable for targeted labeling of specific cell proteins. Using streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can interact with biotinylated antibodies on cell surface receptors, facilitating fluorescence-based imaging and sensing applications.

DPPE-PEG5000 is a PEG lipid functional terminal group utilized for synthesizing liposomes (LPs) and designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) with biotin modification and carboxyl ends can further couple with other biomolecules. These functionalized nanoparticles target specific cellular proteins for labeling. Using streptavidin as a linker, the biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.

DPPE-PEG350 is a PEG lipid-functional end group utilized in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. These liposome nanoparticles (LNPs) feature biotin modifications and carboxyl end groups, allowing further coupling with other biomolecules. Functionalized nanoparticles are employed for targeted labeling of specific cellular proteins. Using streptavidin as a linker, biotinylated PEG-lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.